Evidence map›Paper›PMID 22403645›Full record

ArticlePloS one2012

Listeriolysin o is strongly immunogenic independently of its cytotoxic activity.

Javier A Carrero, Hector Vivanco-Cid, Emil R Unanue

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. RecombinantFrontiers in microbiology · 2022
    Article
  4. Review
  5. Innate and Adaptive Immune Responses duringMicrobiology spectrum · 2019
    Article
  6. Article
  7. Review
  8. RecombinantProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  9. Listeriolysin O: from bazooka to Swiss army knife.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH.Frontiers in cellular and infection microbiology · 2014
    Article
  18. Article
  19. Article
  20. Role of pore-forming toxins in bacterial infectious diseases.Microbiology and molecular biology reviews : MMBR · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Javier A CarreroDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America. jacarrer@wustl.edu
Hector Vivanco-Cid
Emil R Unanue
Washington University in St. Louis · USUniversidad Veracruzana · MX

Funding

IMMUNITY TO INTRACELLULAR PATHOGENSR01AI062832 · NIAID · WASHINGTON UNIVERSITY · PI UNANUE, EMIL RAPHAEL · 2005 to 2014
$3.7M
NIAID NIH HHS AI062832NIAID NIH HHS R01 AI062832
6 · The paper itself

Abstract

The presentation of microbial protein antigens by Major Histocompatibility Complex (MHC) molecules is essential for the development of acquired immunity to infections. However, most biochemical studies of antigen processing and presentation deal with a few relatively inert non-microbial model antigens. The bacterial pore-forming toxin listeriolysin O (LLO) is paradoxical in that it is cytotoxic at nanomolar concentrations as well as being the source of dominant CD4 and CD8 T cell epitopes following infection with Listeria monocytogenes. Here, we examined the relationship of LLO toxicity to its antigenicity and immunogenicity. LLO offered to antigen presenting cells (APC) as a soluble protein, was presented to CD4 T cells at picomolar to femtomolar concentrations- doses 3000-7000-fold lower than free peptide. This presentation required a dose of LLO below the cytotoxic level. Mutations of two key tryptophan residues reduced LLO toxicity by 10-100-fold but had no effect on its presentation to CD4 T cells. Thus there was a clear dissociation between the cytotoxic properties of LLO and its very high antigenicity. Presentation of LLO to CD8 T cells was not as robust as that seen in CD4 T cells, but still occurred in the nanomolar range. APC rapidly bound and internalized LLO, then disrupted endosomal compartments within 4 hours of treatment, allowing endosomal contents to access the cytosol. LLO was also immunogenic after in vivo administration into mice. Our results demonstrate the strength of LLO as an immunogen to both CD4 and CD8 T cells.

Indexed as

Amino Acid SequenceAnimalsAntigen PresentationAntigen-Presenting CellsBacterial ToxinsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesEndosomesHeat-Shock ProteinsHemolysin ProteinsImmunizationMiceProtein TransportBacterial ToxinsHeat-Shock ProteinsHemolysin ProteinshlyA protein, Listeria monocytogenes

Identifiers

PMID22403645
PMCPMC3293810
OpenAlexW2019786351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.